Home › Interstitiële longziekten › Kansas › Kansas City
Interstitiële longziekten klinische studies in Kansas City, KS
13 studies voor Interstitiële longziekten zoeken deelnemers op locaties in en rond Kansas City (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
RekruterenFase 3
- University of Kansas Medical Center, Kansas City
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
RekruterenFase 3
- University of Kansas Medical Center, Kansas City
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RekruterenFase 3
- USA002, Kansas City
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
RekruterenFase 2
- University of Kansas Medical Center, Kansas City
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
RekruterenFase 2
- Clinical Research Site, Kansas City
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RekruterenObservatieonderzoek
- University of Kansas Medical Center, Kansas City
Platform Clinical Study for Conquering Scleroderma
RekruterenFase 2
- University of Kansas School of Medicine, Kansas City
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
RekruterenFase 2/3
- University of Kansas Medical Center, Kansas City
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
RekruterenFase 2
- The University of Kansas Medical Center Research Institute, Kansas City
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
RekruterenFase 3
- University of Kansas Medical Center, Kansas City
Interstitial Lung Disease Research Unit Biobank
RekruterenObservatieonderzoek
- The University of Kansas Medical Center, Kansas City
Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
RekruterenFase 1Gezonde vrijwilligers welkom
- University of Kansas Medical Center, Kansas City
Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
RekruterenObservatieonderzoek
- University of Kansas, Kansas City
Interstitiële longziekten studies in andere steden
- New York City, NY18 studies
- Philadelphia, PA16 studies
- Los Angeles, CA14 studies
- Charleston, SC13 studies
- Durham, NC13 studies
- Chicago, IL12 studies
- Houston, TX12 studies
- Aurora, CO11 studies
- Ann Arbor, MI11 studies
- Salt Lake City, UT9 studies
- Dallas, TX9 studies
- Boston, MA9 studies
Andere studies in Kansas City
- Cardiovasculaire ziekte14 studies
- Hartfalen13 studies
- Obesitas13 studies
- Cystische fibrose13 studies
- Borstkanker12 studies
- Blasenkanker12 studies
- Acute myeloïde leukemie12 studies
- Prostaatkanker12 studies
- Niet-kleincellige longkanker11 studies
- Longkanker11 studies
- COPD9 studies
- Astma8 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.